A Prevotella result on a GI-MAP test describes a group of bacteria in a stool sample. It does not identify every species or strain, explain a symptom on its own, or diagnose rheumatoid arthritis. The useful starting point is the exact result, its units and the reference printed beside it—not whether an online article calls Prevotella “good” or “bad.”
On this page
Why species and strain matter
Prevotella spp. is a group label. Prevotella copri is a species name commonly used in gut research; a strain identifies a more specific organism within a species. These levels are not interchangeable. The GI-MAP sample report lists Prevotella spp., so that line should not be read as a strain-level P. copri identification. [4]
Research illustrates why this matters. A 2023 study examined 13 P. copri strains obtained from people with rheumatoid arthritis and healthy controls. The researchers sequenced genomes and tested effects in mouse arthritis models. Strains differed in their genetic features and experimental effects; a single genus quantity cannot reveal which of those features a person carries. [1]
What autoimmune research does and does not show
The report places Prevotella under a commensal inflammatory and autoimmune-related category. That heading reflects a research association; it is not an autoimmune diagnosis. In the 2023 study, patient-derived strains produced more severe arthritis in the tested mouse models than control-derived strains. This helps investigate a mechanism, but it does not validate a GI-MAP cutoff for diagnosing arthritis or show that lowering a stool count treats people. [1] [3]
There is also research in very different settings. A 2024 study explored P. copri and a specially formulated food used in malnourished Bangladeshi children, then tested microbial interactions in mice. Its findings concerned particular strains, microbial partners and food components. They do not justify trying to raise Prevotella in an adult with digestive symptoms. The population, intervention and measured outcome all matter. [2]
Read a GI-MAP result example
The laboratory’s public demonstration report shows Prevotella spp. 1.74e7 beside a reference of < 1.00e8. That is 17,400,000 compared with an upper reference of 100,000,000 genome equivalents per gram of stool. The example is below that reference—not absent. It is a demonstration, not your result; use the reference on your own report. [4]
This is not a percentage. The result does not mean Prevotella makes up 17.4% of the microbiome. A quantity per gram and a relative share are different measurements. Our GI-MAP sample-report walkthrough explains scientific notation and result columns. [4]
If your result is flagged high, first check the exact target and reference. The flag alone cannot establish the cause of bloating, an infection requiring antibiotics or an autoimmune condition. The opportunistic-bacteria guide explains why a report category needs clinical context. A 2025 international consensus found that evidence for routine clinical use of microbiome testing remains limited and that treatment decisions cannot rely on one microbiome report. That is broader guidance, not a GI-MAP-specific validation study. [5]
Can the result choose a diet?
No single Prevotella count establishes which diet will help you. Research on microbial food metabolism is not the same as a trial showing that a GI-MAP-guided diet improves your symptoms. The 2024 malnutrition study, for example, tested a defined food and microbial community in a particular setting; it was not a general instruction to increase or eliminate a bacterial group. [2]
For a clinician or dietitian discussion, bring a short record of:
- The symptoms you want to improve and when they started.
- Your usual foods and any recent restrictive diet or major change.
- Recent medicines, antibiotics and supplements, with dates.
- The complete report, including its collection date and other findings.
Agree on a meaningful goal—such as improving a specific symptom or maintaining adequate nutrition—and how progress will be assessed. Avoid treating a lower number as the goal by itself.
Common questions
Does high Prevotella mean rheumatoid arthritis?
No. A stool group result cannot establish arthritis or its cause. Joint symptoms need their own clinical assessment; the research above does not replace that assessment.
Is GI-MAP a Gram stain or a culture for Prevotella?
No. Prevotella is described as Gram-negative in the laboratory’s guide, but GI-MAP measures stool DNA with qPCR. That result is not a microscopy Gram stain, a cultured isolate or an antibiotic-susceptibility result. [3]
Does a low or below-detection result mean I need to increase it?
No. “<dl” means below the assay’s detectable limit, not proof of complete absence. A detection label alone does not establish a deficiency or a need for a supplement. [4]
Can stool Prevotella diagnose an infection elsewhere?
No. This is a stool measurement. An oral, vaginal or other site-specific concern needs assessment and any appropriate testing at that site; a shared bacterial name does not establish the same condition.
Sources and review
Sources checked November 18, 2026. Manufacturer material establishes the report format; research findings are kept separate from clinical diagnoses and treatment recommendations.
- Nii et al.: P. copri strains from rheumatoid arthritis patients and controls, 2023
- P. copri, microbial interactions and a therapeutic food for malnutrition, 2024
- Diagnostic Solutions Laboratory: GI-MAP interpretive guide, 2025 edition
- Diagnostic Solutions Laboratory: public sample report, notation key and page 3
- International consensus statement on microbiome testing in clinical practice, 2025
This article has been reviewed by Madison Ordway, FDN-P. For a correction or source question, contact Gi Map Test.